Lindbrook Capital’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
SSM
DRZID
Lindbrook Capital's OGN Position: Q1 2025 in Review
Lindbrook Capital reduced its Organon & Co (OGN) stake by 1.7% in Q1 2025, selling an estimated $569 and leaving 2,096 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.
Lindbrook Capital first reported a position in OGN in Q2 2021 and has held it in 16 quarters since. The position peaked at $66.4K in Q2 2024. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.
- Lindbrook Capital held 2,096 shares of Organon & Co worth $31.2K as of Q1 2025.
- Lindbrook Capital sold 37 Organon & Co shares in Q1 2025, an estimated $569.
- Organon & Co made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1172 holding.
- Lindbrook Capital first reported a position in Organon & Co in Q2 2021 and has held it in 16 quarters since.
- Lindbrook Capital's Organon & Co position peaked at $66.4K in Q2 2024.
- 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.